DLD Asset Management »

Atyr Pharma shares owned by DLD Asset Management

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by DLD Asset Management from 13F filings

Historical chart of DLD Asset Management investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by DLD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by DLD Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $281k 390k 0.72

More positions owned by DLD Asset Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Centrus Energy Corp Cl A Put Option (LEU)
Echostar Corp Note 3.875%11/3 (Principal)
Bofa Fin MTNF 0.600% 5/2 (Principal)
Halozyme Therapeutics Note 1.000% 8/1 (Principal)
Ishares Tr Ishares Biotech Put Option (IBB)
Spirit Aerosystems Note 3.250%11/0 (Principal)
Makemytrip Limited Mauritius Note 2/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Progress Software Corp Note 1.000% 4/1 (Principal)
Ionis Pharmaceuticals Note 1.750% 6/1 (Principal)
Starwood Ppty Tr Note 6.750% 7/1 (Principal)
Dropbox Note 3/0 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Bristol Myers Squibb (BMY)

View all positions for DLD Asset Management

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
UBS Group
State Street Corporation
Geode Capital Management
Affinity Asset Advisors
Millennium Management
Susquehanna International
Rosalind Advisors
Artia Global Partners
Jane Street
Citadel Advisors
GSA Capital Partners

View all funds holding Atyr Pharma